APA (7th ed.) Citation

SA, A., MAY, A., Z, A., HO, A., A, A., MH, S., . . . AY, A. (2024). Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: Pooled analysis of three clinical trials. Therapeutic advances in medical oncology, 16, 17588359241275387. https://doi.org/10.1177/17588359241275387

Chicago Style (17th ed.) Citation

SA, Almansour, et al. "Antithrombotic Utilization, Adverse Events, and Associations with Treatment Outcomes in Multiple Myeloma: Pooled Analysis of Three Clinical Trials." Therapeutic Advances in Medical Oncology 16 (2024): 17588359241275387. https://doi.org/10.1177/17588359241275387.

MLA (9th ed.) Citation

SA, Almansour, et al. "Antithrombotic Utilization, Adverse Events, and Associations with Treatment Outcomes in Multiple Myeloma: Pooled Analysis of Three Clinical Trials." Therapeutic Advances in Medical Oncology, vol. 16, 2024, p. 17588359241275387, https://doi.org/10.1177/17588359241275387.